Medical Physics and Applied Radiation Sciences Department, McMaster University, Hamilton, Ontario, Canada L8S 4K1.
Radiat Res. 2010 Jun;173(6):769-78. doi: 10.1667/RR1895.1.
We examined bystander cell death produced in T98G cells by exposure to irradiated cell conditioned medium (ICCM) produced by high-energy 20 MeV electrons at a dose rate of 10 Gy min(-1) and doses up to 20 Gy. ICCM induced a bystander response in T98G glioma cells, reducing recipient cell survival by more than 25% below controls at 5 and 10 Gy. Higher doses increased survival to near control levels. ICCM was analyzed for the presence of transforming growth factor alpha (TGF-alpha) and transforming growth factor beta1 (TGF-beta1). Monoclonal antibodies for TGF-alpha (mAb TGF-alpha) and TGF-beta1 (mAb TGF-beta1) were added to the ICCM to neutralize any potential effect of the cytokines. The results indicate that TGF-alpha was not present in the ICCM and addition of mAb TGF-alpha to the ICCM had no effect on bystander cell survival. No active TGF-beta1 was present in the ICCM; however, addition of mAb TGF-beta1 completely abolished bystander death of reporter cells at all doses. These results indicate that bystander cell death can be induced in T98G glioma if a large enough radiation stress is applied and that TGF-beta1 plays a downstream role in this response.
我们通过暴露于由高能 20 MeV 电子以 10 Gy min(-1)的剂量率和高达 20 Gy 的剂量产生的照射细胞条件培养基 (ICCM) 来检查 T98G 细胞中产生的旁观者细胞死亡。ICCM 在 T98G 神经胶质瘤细胞中诱导了旁观者反应,使受者细胞的存活率比对照降低超过 25%,在 5 和 10 Gy 时。更高的剂量使存活率接近对照水平。分析了 ICCM 中是否存在转化生长因子 alpha (TGF-alpha) 和转化生长因子 beta1 (TGF-beta1)。用于 TGF-alpha (mAb TGF-alpha) 和 TGF-beta1 (mAb TGF-beta1) 的单克隆抗体被添加到 ICCM 中,以中和细胞因子的任何潜在影响。结果表明,ICCM 中不存在 TGF-alpha,并且向 ICCM 中添加 mAb TGF-alpha 对旁观者细胞存活没有影响。ICCM 中不存在活性 TGF-beta1;然而,在所有剂量下,添加 mAb TGF-beta1 均可完全消除报告细胞的旁观者死亡。这些结果表明,如果施加足够大的辐射应激,T98G 神经胶质瘤中可以诱导旁观者细胞死亡,并且 TGF-beta1 在该反应中起下游作用。